Buffett, Bloomberg, & 48 Congress Members Are Buying 1 Sector
Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, "The Walmart Family", Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market... The last time we saw the world's wealthiest investors move their cash into this corner of the market, Stocks exploded 2,020%, 5,609% Even as high as 8,437% in just ONE year. Now, it's all happening again.
Financials
| Curr Year EPS Estimate | -5.27 |
| Next Quarter EPS Estimate | -1.42 |
| Profit Margin | -1212.19% |
| Operating Margin | -1,247.99 |
| Return on Assets | -0.28 |
| Return on Equity | -0.52 |
| Revenue | 43.1M |
| Earnings Per Share | -5.45 |
| Revenue Per Share | 0.45 |
| Gross Profit | -415,328,992 |
| Quarterly Revenue Growth | -0.24 |
General
| Name | Intellia Therapeutics Inc |
| Ticker | NTLA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 526 |
About Intellia Therapeutics Inc
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of curative therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; NTLA-2002 for the treatment of hereditary angioedema; and NTLA-3001 for alpha-1 antitrypsin deficiency associated lung disease. It also focusses on programs comprising hemophilia A and hemophilia B; and research of proprietary programs focused on developing engineered cell therapies to treat various cancers and autoimmune diseases. In addition, the company offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. It has license and collaboration agreement with Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; AvenCell Therapeutics, Inc. to develop allogeneic universal CAR-T cell therapies, and co-develop and co-commercialize allogeneic universal CAR-T cell products for an immuno-oncology indication; SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases; Kyverna Therapeutics, Inc. for the development of an allogeneic CD19 CAR-T cell therapy for the treatment of a variety of B cell-mediated autoimmune diseases; and ONK Therapeutics, Ltd. for the development of engineered NK cell therapies to cure patients with cancer. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Earnings
FireAid, with Billie Eilish and Lady Gaga, is the latest in a long line of massive benefit concerts
Billie Eilish, Sting, Red Hot Chili Peppers and others in a efforts, is the latest event to combine music and philanthropy.
Polymarket Bets Turn Bullish On 2025 Dogecoin ETF After Bitwise Move
Bets favoring approval of a Dogecoin (CRYPTO: DOGE) exchange-traded fund in 2025 surged on Polymarket after cryptocurrency fund manager Bitwise Asset Management formally applied with the SEC.
The Stock Rebuilding America - Ad
Wildfires and hurricanes wreaked havoc, but one company is turning debris into dollars.
Dan Ives Expects Meta And Microsoft To Stand Firm On $60 - $80 Billion AI Spending Plans Amid DeepSeek's Disruptive AI Model
Wedbush Securities analyst Dan Ives expects Meta Platforms Inc. and Microsoft Corp. to stand firm on their ambitious artificial intelligence spending plans during their upcoming earnings calls, despite recent market jitters over Chinese AI startup DeepSeek's emergence.
Stock market today: Asian stocks advance ahead of the Fed's rate decision as panic over AI fades
HONG KONG (AP) — Asian stocks advanced Wednesday in thin Lunar New Year trading following a rebound on Wall Street driven by tech stocks as the panic over Chinese AI company DeepSeek faded.
Stunning Trump Exec Order Leaked - Ad
This secret document contains stunning details about Donald Trump's big Day 1 announcement... His allies are calling it Trump's Secret Manhattan Project. Because if what's in this leaked document is even half true (and trust me, it comes from a very, very credible source)... It will be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years. And over the next 100 days, it could set off a huge dose of "Trump Market Euphoria"... igniting a buying frenzy in very specific AI stocks... unlike anything we've seen so far.
Magnificent 7 Earnings Ahead: 3 ETFs To Ride The Wave
Earnings season in full swing, attention on tech giants known as Magnificent 7: 3 ETFs to consider.
F5 Sees Big Wins in Multi-Cloud, AI Security, and IT Refresh, Analysts Forecast More Upside
F5 Inc (NASDAQ: FFIV) reported strong Q1 results, beating revenue and EPS estimates. The stock gained as analysts raised price targets and expectations for further growth from IT budgets, data center refresh, and AI demand.
Turning Chaos into Cash - Ad
A small-cap stock is profiting from disaster recovery, with big contracts and insider confidence.
Did DeepSeek copy ChatGPT? Trump adviser thinks so
Did the upstart copy ChatGPT to make the artificial intelligence technology that this week?
What's Going On With Manhattan Associates Shares Wednesday?
Manhattan Associates shares are trading lower on Wednesday after the company announced soft guidance for the 2025 fiscal-year.
The No. 1 Stock for Trump's Second Term? - Ad
Legendary investor Louis Navellier's stock rating system gave a buy rating to ALL of the top 30 performing stocks in the S&P 500 index of Trump's first term... ALL of them! His system is now rating these stocks as a "BUY" for Trump's second term.
AI-assisted works can get copyright with enough human creativity, says US copyright office
Artists can copyright works they made with the help of artificial intelligence, according to a new report by the U.S. Copyright Office that could help clear the way for the use of AI tools in Hollywood, the music industry and other creative fields.
Wall Street's Most Accurate Analysts Weigh In On 3 Consumer Stocks With Over 5% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks.
Love or Hate Him -- You Have To See What Elon Could Do Next - Ad
It's not electric vehicles, green energy or space travel that Elon Musk will be remembered for.
Shipments of uranium ore can resume under agreement reached with the Navajo Nation
Shipments of uranium ore from just south of the Grand Canyon are expected to resume in February after the Navajo Nation reached a settlement with the mining company, clearing the way for trucks to transport the ore across the largest Native American reservation in the U.S.
6 Clean Energy Stocks Face Challenges, Opportunities Ahead Of Earnings
Analyst revises ratings/price forecast on clean energy stocks ahead of earnings release. Highlights key areas to watch for each company.
FORGET Crypto, FORGET Stocks... Do THIS Instead... - Ad
With everyone scrambling for the next hot AI stock or cryptocurrency... One man is saying FORGET them all. Because his strategy could lead to bigger gains than you'd see from stocks, crypto or anything else you might be seeing. It's shown his readers gains of 85% in 14 days... 55% gains in 2 days... And even 222% in 8 days!
Ozempic Receives FDA Approval To Treat Kidney Disease
The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease in patients who also have type 2 diabetes.
UK Faces Triple Threat as Economic Uncertainty Hits
The United Kingdom faces a decline in stock market listings, demographic crisis, and diminishing tax revenue with an exodus of high earners.
Crypto Stocks Surge Amid Market Boom - Ad
Crypto stocks are on fire as Bitcoin hits all-time highs. One under-the-radar company is leading the charge, managing $2.1 billion in client assets and seeing record trading volumes. With crypto adoption skyrocketing, this could be a game-changing opportunity.
7 AI Infrastructure Stocks Plunge Over 20%, Outpace Semiconductor Rout As DeepSeek Upends Investment Landscape
The launch of DeepSeek affects the AI boom including the power, cooling and data center giants that once rode the AI euphoria, which now have single-day losses exceeding 20%.
Nvidia Says DeepSeek An 'Illustration' Of How New AI Models Can Be Created While Being Export-Control Compliant Amid $600 Billion Market Value Plunge
Nvidia Corp. has thrown its support behind China's DeepSeek R1 artificial intelligence model, calling it "an excellent AI advancement" even as the startup's emergence triggered a historic $600 billion plunge in the chipmaker's market value on Monday.
How to Invest in Trump's Crypto Revolution with Just $25 - Ad
Since Donald Trump was elected, Bitcoin has soared to over $104,000. That's a six-figure price tag -- PER COIN! But there's a much less expensive -- and better way to take advantage of Trump's crypto revolution. I'm talking about a way to make huge gains with just $25. But you need to be fast.
Trump White House Puts DeepSeek Under National Security Scanner: 'Wake-Up Call To The American AI Industry'
The White House is reviewing China's DeepSeek AI for potential national security risks, amid growing concerns over intellectual property theft and its impact on U.S. AI dominance.
Microsoft reports 10% quarterly profit growth as it works to show AI investments paying off
REDMOND, Wash. (AP) — Microsoft Corp. said Wednesday that its profit for the October-December quarter grew 10% from the same time last year as it works to capitalize on the huge amounts of money it has spent to advance its artificial intelligence technology.
He Called Bitcoin to $100k... Now He Says This Coin Is Next - Ad
Juan Villaverde may be America's top crypto expert. According to Juan's timing model, we are entering what could be the biggest bull market in crypto's history. With America's first crypto president in office, it could be the biggest gains the market has ever seen. And one special coin could skyrocket.
Cathie Wood Dumps Tesla Stock Ahead Of Q4 Earnings, Ark Invest Loads Up On Amazon
On Tuesday, Jan. 28, 2025 Cathie Wood-led Ark Invest sold shares of Tesla ahead of its fourth-quarter earnings. Wood purchased Amazon shares on the same day.
Sysco's Sales Perform Well, But Case Growth Concerns Weigh On Stock, Say Analysts
Sysco Corp's second-quarter earnings showed slight misses in adjusted EBITDA, totaling $969 million, and a minor decline in case growth for US Foodservice. Despite challenges, a lower tax rate contributed to EPS of $0.93.
Seven Unknown AI Stocks That Could Dominate the Next Six Years - Ad
The original "Magnificent Seven" stocks generated 16,800% over the last 20 years. But now a new set of AI stocks is set to take over. Alex Green dubs them "The Next Magnificent Seven." And he's arguing that just $1,000 in each could turn into more than $1 million in less than six years.
Jeff Bezos-Backed Perplexity Revises TikTok Merger Deal, Proposes Giving US Government 50% Stake: Report
Jeff Bezos-backed Perplexity AI has proposed merging with TikTok's U.S. operations, offering the U.S. government a 50% stake via a $300 billion IPO while allowing ByteDance to retain ties without the proprietary recommendation algorithm.
A South Florida luxury condo project is planned for site where building collapse killed 98 people
SURFSIDE, Fla. (AP) — A Dubai-based developer plans to build a 12-story luxury condominium project on the South Florida site where in 2021, killing 98 people.
Legendary Investor: Buy These "Trump Stocks" Now - Ad
Within the first week of Trump's election, several stocks exploded for double- and triple-digit gains. According to legendary investor Louis Navellier, this is just the beginning of what could be the best four-year period for stocks in U.S. history.
Nvidia Stock Slides Overnight On Robinhood As China's DeepSeek Sparks Doubts Over GPU Spending Frenzy — Chamath Palihapitiya Highlights Report Indicating AI Holy Grail Cracked
Nvidia shares fell 3.12% after China's DeepSeek unveiled an AI model that delivers cutting-edge performance at a fraction of the cost, raising concerns over the necessity of massive GPU-related spending.
Edmunds' hybrid SUV test: 2025 Hyundai Tucson Hybrid vs 2025 Toyota RAV4 Hybrid
Hybrids are hot right now, and you have lots of choices if you’re considering a hybrid SUV. For years, the Toyota RAV4 Hybrid has been the go-to model for hybrid SUV shoppers.
Is This Defi Coin Your Next "10-Bagger" Investment? - Ad
Our #1 pick in decentralized finance is largely overlooked by mainstream investors (for now). This governance token could skyrocket as DeFi adoption surges with the smart money and institutions.
Czech Central Bank Considering 5% Bitcoin Reserve
The Czech National Bank (CNB) could become the first Western central bank known to allocate a portion of its reserves to Bitcoin (CRYPTO: BTC).
Fed Set To Signal No Rush To Cut Rates As Wall Street Awaits Policy Clarity
Fed expected to keep rates steady, but Wall Street desperate for clarity on when next cut will come. Markets hoping for a dovish signal, but Powell may not deliver. Odds of two cuts in 2025 at 93%, with $4 payout for single cut and $6 for no cuts.
Is Artificial Intelligence the Biggest Bubble in History? - Ad
Is it any surprise 31 billionaires (including: Warren Buffett, Elon Musk, Jeff Bezos, and more) are quietly unloading their OWN stocks at record pace? They're getting OUT of AI (and Tech Stocks) before it's too late. But why? And WHERE are they moving their cash for the biggest profits, in 2025?
SoFi Stock Falls On Soft Guidance Despite 'Strong Quarter' With Record Member Growth, Loan Originations: Analyst
SoFi reported better-than-expected Q4 financial results on Monday. But fiscal 2025 profit guidance dragged the stock down on Monday.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.